Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
18.1M
-
Shares change
-
+633K
-
Total reported value, excl. options
-
$128M
-
Value change
-
+$4.5M
-
Number of buys
-
16
-
Number of sells
-
-16
-
Price
-
$7.04
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2017
42 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q3 2017.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.1M shares
of 71.9M outstanding shares and own 25.23% of the company stock.
Largest 10 shareholders include SAIF Advisors Ltd (10.8M shares), ORBIMED ADVISORS LLC (2.67M shares), RENAISSANCE TECHNOLOGIES LLC (2.17M shares), GLG Partners LP (759K shares), MORGAN STANLEY (650K shares), DEUTSCHE BANK AG\ (204K shares), Eqis Capital Management, Inc. (150K shares), WOLVERINE ASSET MANAGEMENT LLC (99.2K shares), STATE STREET CORP (78.3K shares), and WELLINGTON MANAGEMENT GROUP LLP (69.1K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.